Cita APA (7a ed.)

Robak, P., Szemraj, J., Mikulski, D., Drozdz, I., Juszczak, K., Jarych, D., . . . Robak, T. (2021). Prognostic Value of Resistance Proteins in Plasma Cells from Multiple Myeloma Patients Treated with Bortezomib-Based Regimens. MDPI AG.

Cita Chicago Style (17a ed.)

Robak, Paweł, et al. Prognostic Value of Resistance Proteins in Plasma Cells from Multiple Myeloma Patients Treated with Bortezomib-Based Regimens. MDPI AG, 2021.

Cita MLA (8a ed.)

Robak, Paweł, et al. Prognostic Value of Resistance Proteins in Plasma Cells from Multiple Myeloma Patients Treated with Bortezomib-Based Regimens. MDPI AG, 2021.